RetefastReteplase
Retefast is marketed by Cipla. 1 pack on NPPA's price list for July 2026, containing Reteplase.
- Packs listed
- 1
- Lowest MRP
- ₹35,652
- Per unit
- ₹3,565
- Price-controlled packs
- 0 of 1
- Dosage forms
- 1
Packs and prices
- ₹35,652Retefast Kit 18 mg Injection 10 mlReteplase Injection 18 mg · ₹3,565 per ml
The same composition from other brands
Packs with the identical filed composition, form and strength. A different brand is not automatically interchangeable: ask your doctor or pharmacist.
Reteplase Injection 18 mg
- ₹20,381/injectionRetelex · 2 injectionAbbott Healthcare · MRP ₹40,763
- ₹43,418/injectionRetefuse · 1 injectionLupin · MRP ₹43,418
2 other brands of this composition on the price list; the 2 lowest per ml are shown. All Reteplase packs
The company
Cipla has 2,443 packs on the price list, and CDSCO has named it as the manufacturer of 23 failed batches since Jun 2013. Company record
Prices are the maximum retail prices each company filed with the National Pharmaceutical Pricing Authority (NPPA) for July 2026, read from NPPA's Pharma Sahi Daam service on 2 Oct 2026. A price in a shop can be lower; it may not lawfully be higher. Failed batches are those CDSCO and state laboratories declared not of standard quality. This is a record of prices and filings, not medical advice: do not change a medicine without your doctor or pharmacist. Source: NPPA and CDSCO, Government of India. About this record.